Clarity Pharmaceuticals Ltd CU6.AX
AUD2.69
Last Updated: Aug 07, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
CU6.AX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Clarity Pharmaceuticals Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Clarity Pharmaceuticals Ltd. Stock Analysis CU6.AX
Australia Health Care Small Cap Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. The company is headquartered in Eveleigh, New South Wales. The company went IPO on 2021-08-25. The firm is focused on developing targeted copper theranostics based on its SAR Technology Platform. The company is progressing clinical trials with its approximately three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. Its lead product, SAR-bisPSMA, is progressing through over three clinical trials: one theranostic trial (SECuRE) and two Phase III diagnostic trials (CLARIFY and AMPLIFY). SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2). SAR-bisPSMA is developed for diagnosing, staging, and treating prostate cancer that expresses prostate-specific membrane antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer.
Clarity Pharmaceuticals Ltd (CU6.AX) Chart
Financial Metrics & Statements of Clarity Pharmaceuticals Ltd (CU6.AX)
FAQ's for Clarity Pharmaceuticals Ltd (CU6.AX)
- As of August 2026, Clarity Pharmaceuticals Ltd CU6.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clarity Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Clarity Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Clarity Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Clarity Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Clarity Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Clarity Pharmaceuticals Ltd (CU6.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
